In a previous study we showed that recombinant human tumor necrosis factor-a (rTNF-tr) has no cytolytic effect on Meth A fibrosarcoma cells in virro but that it has a strong anti-tumor activity in vivo. In the present work, we define the in vivo mode of action of rTNF-a on solid-form Meth A fibrosar
Genetic engineering of a recombinant fusion possessing anti-tumor F(ab′)2 and tumor necrosis factor
✍ Scribed by Jim Xiang; Terence Moyana; Yumin Qi
- Book ID
- 119524664
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 610 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0168-1656
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Over-expression of the proto-oncogene HER2/neu in breast cancer and certain other tumors appears to be a central mechanism that may be partly responsible for cellular progression of the neoplastic phenotype. Transfection of mammalian cells and over-expression of HER2/neu appears to result in reduced
The activity and toxicity of rMuTNF, alone or combined with rat recombinant interferon gamma (rRIFNy), was tested in inbred WAG rats bearing a weakly immunogenic colon adenocarcinoma (CC53 I). The tumor was implanted S.C. or under the renal capsule. A single i.v. injection of IOpg of rMuTNF in non-t